Serum Apolipoprotein A-I Predicts Response of Rectal Cancer to Neoadjuvant Chemoradiotherapy
Su-ping Guo,1,2,* Chen Chen,1,2,* Zhi-fan Zeng,1,2 Qiao-xuan Wang,1,2 Wu Jiang,2,3 Yuan-hong Gao,1,2 Hui Chang1,2 1Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China; 2State Key Laboratory of Oncology in South China, Collaborative...
Main Authors: | Guo S, Chen C, Zeng Z, Wang Q, Jiang W, Gao Y, Chang H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-03-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/serum-apolipoprotein-a-i-predicts-response-of-rectal-cancer-to-neoadju-peer-reviewed-article-CMAR |
Similar Items
-
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
by: Jian Wang, et al.
Published: (2021-07-01) -
Potential predictive factors for pathologic complete response after the neoadjuvant treatment of rectal adenocarcinoma: a single center experience
by: Feryel Letaief, et al.
Published: (2017-06-01) -
Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response
by: Filip Pazdirek, et al.
Published: (2020-07-01) -
The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
by: J. Martinez-Useros, et al.
Published: (2018-02-01) -
A lower cut-off for lymph node harvest predicts for poorer overall survival after rectal surgery post neoadjuvant chemoradiotherapy
by: Charleen Shanwen Yeo, et al.
Published: (2020-03-01)